0001700389-17-000002.txt : 20170526
0001700389-17-000002.hdr.sgml : 20170526
20170526111527
ACCESSION NUMBER: 0001700389-17-000002
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20170526
DATE AS OF CHANGE: 20170526
EFFECTIVENESS DATE: 20170526
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kleo Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001700389
IRS NUMBER: 475508437
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-287320
FILM NUMBER: 17872429
BUSINESS ADDRESS:
STREET 1: 25 SCIENCE PARK, SUITE 2D
STREET 2: 150 MUNSON ST.
CITY: NEW HAVEN
STATE: CT
ZIP: 06511
BUSINESS PHONE: 203-691-6332
MAIL ADDRESS:
STREET 1: 25 SCIENCE PARK, SUITE 2D
STREET 2: 150 MUNSON ST.
CITY: NEW HAVEN
STATE: CT
ZIP: 06511
D/A
1
primary_doc.xml
X0707
D/A
LIVE
0001700389
Kleo Pharmaceuticals, Inc.
25 Science Park, Suite 2D
150 Munson St.
New Haven
CT
CONNECTICUT
06511
203-691-6332
DELAWARE
None
None
Corporation
true
2015
David
Spiegel
25 Science Park, Suite 2D
150 Munson Street
New Haven
CT
CONNECTICUT
06511
Executive Officer
Director
Roy
Prieb
25 Science Park, Suite 2D
150 Munson Street
New Haven
CT
CONNECTICUT
06511
Executive Officer
Director
Declan
Doogan
45 Ocean Crest Way
Unit 1032
Palm Coast
FL
FLORIDA
32137
Director
John
W.
Childs
c/o J.W. Childs Associates, L.P.
500 Totten Pond Road, 6th Floor
Waltham
MA
MASSACHUSETTS
02451
Director
Charles
G.
Drake
c/o Columbia University Medical Center
177 Fort Washington Avenue, St. 6GN-435
New York
NY
NEW YORK
10032
Director
Douglas
Manion
25 Science Park, Suite 2D
150 Munson St.
New Haven
CT
CONNECTICUT
06511
Executive Officer
Pharmaceuticals
Decline to Disclose
- 06b
true
0001700389-17-000001
2016-08-29
true
true
false
0
Indefinite
11000000
Indefinite
false
9
0
true
0
true
0
true
false
Kleo Pharmaceuticals, Inc.
/s/ Douglas Manion
Douglas Manion
Chief Executive Officer
2017-05-26